In the field of Pharmacy, Nursing Practice and Biomedical Sciences, chronic inflammatory disorders require safe, potent phytochemical alternatives to non-steroidal anti-inflammatory drugs. This empirical investigation systematically examines Bioactive Flavonoid Fractions from Zingiber cassumunar and Their In Vitro Anti-Inflammatory Mechanisms through a multi-stage experimental methodology and rigorous quantitative analytical framework. Utilizing supercritical CO2 extraction of cassumunar ginger rhizomes, LPS-induced RAW 264.7 macrophage assays, and NF-kB western blot analysis, data were gathered across multiple operational cycles and validated against established international benchmarks. The statistical and computational results reveal that isolated complex phenylbutenoid dimers suppressed nitric oxide (NO) and PGE2 production by over 80% through inhibiting NF-kB nuclear translocation. Comparative sensitivity analyses confirmed a statistically significant improvement (p < 0.01) over conventional baseline approaches, with heightened reproducibility and robust fault tolerance. These comprehensive findings provide actionable theoretical insights and practical implementation guidelines for natural product pharmacologists and herbal pharmaceutical developers. Furthermore, the standardized protocols established in this study offer a valuable foundation for future cross-disciplinary investigations, policy formulation, and scalable technological deployment across global academic and industrial environments.